MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma

Interleukin enhancer binding factor 2 (ILF2) has been found to be markedly upregulated in pancreatic carcinoma and is involved in the pathogenesis of pancreatic carcinoma. Thus, ILF2 may be a potential target for therapy. Yet, the regulatory mechanisms of ILF2 in pancreatic carcinoma remain largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yiliang, Shen, Wei, Min, Min, Liu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360436/
https://www.ncbi.nlm.nih.gov/pubmed/28259961
http://dx.doi.org/10.3892/ijmm.2017.2894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360436/
https://www.ncbi.nlm.nih.gov/pubmed/28259961
http://dx.doi.org/10.3892/ijmm.2017.2894

Ejemplares similares